SLDE:NASDAQSlide Insurance Holdings, Inc. Analysis
Data as of 2026-06-14 - not real-time
$16.70
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Slide Insurance Holdings trades at a deep discount to both its historical earnings multiples and the broader property‑casualty sector, with a trailing PE well under the industry average and a DCF‑derived fair value that suggests more than fifty percent upside. Revenue growth is robust and margins are exceptionally high, delivering a return on equity that dwarfs most peers. However, the stock is hovering near a key support level, insider selling has been noted, and technical indicators (bearish MACD, lower‑mid RSI, decreasing volume) point to short‑term pressure.
Market sentiment is extremely bullish as reflected by the “Extreme Greed” reading, yet the combination of high 30‑day volatility and a neutral trend underscores the need for caution. The company’s low beta suggests limited systematic risk, but the current price action and material insider activity warrant a measured approach.
Market sentiment is extremely bullish as reflected by the “Extreme Greed” reading, yet the combination of high 30‑day volatility and a neutral trend underscores the need for caution. The company’s low beta suggests limited systematic risk, but the current price action and material insider activity warrant a measured approach.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near technical support and bearish MACD
- Decreasing volume indicating waning buying pressure
- Insider selling raising short‑term concerns
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Substantial valuation gap versus DCF fair value
- Strong earnings growth and high profitability metrics
- Low beta mitigating broader market swings
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Sustainable high margins and impressive ROE
- Industry tailwinds for specialty property insurance
- Significant upside potential despite current price weakness
Key Metrics & Analysis
Financial Health
Revenue Growth38.20%
Profit Margin38.86%
P/E Ratio4.6
ROE59.66%
ROA17.03%
Debt/Equity3.74
P/B Ratio1.8
Op. Cash Flow$990.1M
Free Cash Flow$768.6M
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI38.5
Support$16.00
Resistance$19.27
MA 20$17.70
MA 50$18.18
MA 200$17.01
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Fair Value$253.36
Target Price$25.20
Upside/Downside50.90%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta0.45
Volatility32.59%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.